AllAnalyst Report
logoMorningstarApril 15, 2021

Thermo Fisher Scientific Inc.: Pause No More: Thermo Fisher Confirms Offer for PPD, Resuming Its Acquisition Strategy

Symbols
TMO
Sector(s)
Healthcare
Rating
Current Price
$452.92
Fair Value
Economic Moat
Stewardship

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).
Quotes from this report
Symbol
NamePriceIndustryCurrencyMarket CapMorningstar RatingEconomic MoatUncertainty RatingFair ValuePrice/Fair Value
TMO
Thermo Fisher Scientific Inc452.92N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Profile

Alex Morozov

Regional Director
Alex Morozov, CFA, is director of European equity research for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. He leads a team of equity analysts based in Europe who cover European and global companies across all major sectors of the economy.Before assuming his current role in 2014, Morozov was head of global healthcare equity research. Previously, he was a senior equity analyst, covering the medical instruments, life sciences, and diagnostics industries. Before joining Morningstar in 2006, Morozov worked in the insurance industry.Morozov holds a bachelor’s degree in finance, with a minor in mathematics, from the University of Missouri. He also holds the Chartered Financial Analyst® designation.